These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6723966)

  • 1. Primary sequence differences between Chido and Rodgers variants of tryptic C4d of the human complement system.
    Hellman U; Eggertsen G; Lundwall A; Engström A; Sjöquist J
    FEBS Lett; 1984 May; 170(2):254-8. PubMed ID: 6723966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chemical structure of the C4d fragment of the human complement component C4.
    Chakravarti DN; Campbell RD; Porter RR
    Mol Immunol; 1987 Nov; 24(11):1187-97. PubMed ID: 3696167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic determinants of human C4, Rodgers and Chido.
    Giles CM
    Exp Clin Immunogenet; 1988; 5(2-3):99-114. PubMed ID: 2483343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4.
    Chakravarti DN; Campbell RD; Gagnon J
    FEBS Lett; 1983 Apr; 154(2):387-90. PubMed ID: 6832377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rodgers (Rg) and Chido (Ch) determinants on human C4: characterization of two C4 B5 subtypes, one of which contains Rg and Ch determinants.
    Roos MH; Giles CM; Demant P; Mollenhauer E; Rittner C
    J Immunol; 1984 Nov; 133(5):2634-40. PubMed ID: 6207239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of tryptic fragments of human C4 expressing Chido and Rodgers antigens.
    Lundwall A; Hellman U; Eggertsen G; Sjöquist J
    Mol Immunol; 1982 Dec; 19(12):1655-65. PubMed ID: 7162521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localisation of Chido and Rodgers determinants to the C4d fragment of human C4.
    Tilley CA; Romans DG; Crookston MC
    Nature; 1978 Dec; 276(5689):713-5. PubMed ID: 83538
    [No Abstract]   [Full Text] [Related]  

  • 8. Definitive RFLPs to distinguish between the human complement C4A/C4B isotypes and the major Rodgers/Chido determinants: application to the study of C4 null alleles.
    Yu CY; Campbell RD
    Immunogenetics; 1987; 25(6):383-90. PubMed ID: 2439447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C4d DNA sequences of two infrequent human allotypes (C4A13 and C4B12) and the presence of signal sequences enhancing recombination.
    Martínez-Quiles N; Paz-Artal E; Moreno-Pelayo MA; Longás J; Ferre-López S; Rosal M; Arnaiz-Villena A
    J Immunol; 1998 Oct; 161(7):3438-43. PubMed ID: 9759862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4.
    Taillon-Miller PA; Shreffler DC
    J Immunol; 1988 Oct; 141(7):2382-7. PubMed ID: 2459207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4.
    Isenman DE; Young JR
    J Immunol; 1984 Jun; 132(6):3019-27. PubMed ID: 6609966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum C4 levels, Chido, Rodgers, and allotypes of C4 component of complement.
    O'Neill GJ; Dupont B
    Transplant Proc; 1979 Mar; 11(1):1102-6. PubMed ID: 452090
    [No Abstract]   [Full Text] [Related]  

  • 13. The genetic control of Chido and Rodgers blood group substances.
    O'Neill GJ
    Semin Hematol; 1981 Jan; 18(1):32-8. PubMed ID: 7010610
    [No Abstract]   [Full Text] [Related]  

  • 14. C4 gene polymorphism in primates: evolution, generation, and Chido and Rodgers antigenicity.
    Paz-Artal E; Corell A; Alvarez M; Varela P; Allende L; Madroño A; Rosal M; Arnaiz-Villena A
    Immunogenetics; 1994; 40(6):381-96. PubMed ID: 7525470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal anti-C4d that demonstrates a specificity related to anti-Ch.
    Giles CM; Ford DS
    Transfusion; 1986; 26(4):370-4. PubMed ID: 3523873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary structure of murine major histocompatibility alloantigens: amino acid sequence of the cyanogen bromide fragment Ia (positions 139-228) from the H-2Kb molecule.
    Uehara H; Ewenstein BM; Martinko JM; Nathenson SG; Kindt TJ; Coligan JE
    Biochemistry; 1980 Dec; 19(26):6182-8. PubMed ID: 7470457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic determinants expressed by human C4 allotypes; a study of 325 families provides evidence for the structural antigenic model.
    Giles CM; Uring-Lambert B; Goetz J; Hauptmann G; Fielder AH; Ollier W; Rittner C; Robson T
    Immunogenetics; 1988; 27(6):442-8. PubMed ID: 2453461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis of the polymorphism of human complement components C4A and C4B: gene size, reactivity and antigenicity.
    Yu CY; Belt KT; Giles CM; Campbell RD; Porter RR
    EMBO J; 1986 Nov; 5(11):2873-81. PubMed ID: 2431902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-ray crystal structure of the C4d fragment of human complement component C4.
    van den Elsen JM; Martin A; Wong V; Clemenza L; Rose DR; Isenman DE
    J Mol Biol; 2002 Oct; 322(5):1103-15. PubMed ID: 12367531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary and tertiary structure of the principal human adenylate kinase.
    Von Zabern I; Wittmann-Liebold B; Untucht-Grau R; Schirmer RH; Pai EF
    Eur J Biochem; 1976 Sep; 68(1):281-90. PubMed ID: 183954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.